Table 2 : Homolog Protein
Subclade
dan Year of
isolation
Homolog Protein
2.3.2
(2012)
H3 HAEMAGGLUTININ HA1 CHAIN
Influenza B hemagglutinin (HA)
PROTEIN (INFLUENZA
RECOMBINANT HA2 CHAIN)
HEMAGGLUTININ FUSION
PEPTIDE G8A MUTANT
uncharacterized protein
Influenza H5 HA head domain VietNam
rdt mutations
HEMAGGLUTININ FUSION
PEPTIDE G8A MUTANT
2.1.3
(2012)
Influenza B hemagglutinin (HA)
Influenza H5 HA head domain VietNam
rdt mutations
HEMAGGLUTININ FUSION
PEPTIDE G8A MUTANT
2.1.3
(2010)
H3 HAEMAGGLUTININ HA1 CHAIN
Influenza B hemagglutinin (HA)
Influenza H5 HA head domain VietNam
rdt mutations
PROTEIN (INFLUENZA
RECOMBINANT HA2 CHAIN)
Gp7-MYH7(1173-1238)-EB1 chimera
protein
uncharacterized protein
2.1.3
(2008)
Influenza B hemagglutinin (HA)
Influenza H5 HA head domain VietNam
rdt mutations
H3 HAEMAGGLUTININ HA2 CHAIN
PROTEIN (INFLUENZA
RECOMBINANT HA2 CHAIN)
uncharacterized protein
4. CONCLUSIONS
The study demonstrated that H5N1 virus
circulating in Indonesia had a form of homotrimer
based on the bioinformatic analysis. Besides, H5N1
virus circulating in Indonesia from 2008 to 2012 had
the number of ligands and homology based on protein
structure.
REFERENCES
Brooks, W.A., Goswami, D., Rahman, M., Nahar, K., Fry,
A.M., Balish, A., Iftekharuddin, N., Azim, T.,
Xu, X., Klimov, A., 2010. Influenza is a major
contributor to childhood pneumonia in a tropical
developing country. Pediatr. Infect. Dis. J. 29,
216–221.
Bruce, E.A., Digard, P., Stuart, A.D., 2010. The Rab11
pathway is required for influenza A virus budding
and filament formation. J. Virol. 84, 5848–5859.
Cheng, X., Zengel, J.R., Xu, Q., Jin, H., 2012a. Surface
glycoproteins of influenza A H3N2 virus
modulate virus replication in the respiratory tract
of ferrets. Virology 432, 91–98.
Cheng, X., Zengel, J.R., Xu, Q., Jin, H., 2012b. Surface
glycoproteins of influenza A H3N2 virus
modulate virus replication in the respiratory tract
of ferrets. Virology 432, 91–98.
Ducatez, M.F., Bahl, J., Griffin, Y., Stigger-Rosser, E.,
Franks, J., Barman, S., Vijaykrishna, D., Webb,
A., Guan, Y., Webster, R.G., 2010. Feasibility of
reconstructed ancestral H5N1 influenza viruses
for cross-clade protective vaccine development.
Proc. Natl. Acad. Sci. 201012457.
Edinger, T.O., Pohl, M.O., Stertz, S., 2014. Entry of
influenza A virus: host factors and antiviral
targets. J. Gen. Virol. 95, 263–277.
Harvey, R., Martin, A.C., Zambon, M., Barclay, W.S.,
2004. Restrictions to the adaptation of influenza
a virus h5 hemagglutinin to the human host. J.
Virol. 78, 502–507.
Lazniewski, M., Dawson, W.K., Szczepińska, T.,
Plewczynski, D., 2017. The structural variability
of the influenza A hemagglutinin receptor-
binding site. Brief. Funct. Genomics.
Li, K., Guan, Y., Wang, J., Smith, G., Xu, K., Duan, L.,
Rahardjo, A., Puthavathana, P., Buranathai, C.,
Nguyen, T., 2004. Genesis of a highly pathogenic
and potentially pandemic H5N1 influenza virus
in eastern Asia. Nature 430, 209.
Luke, C.J., Subbarao, K., 2006. Vaccines for pandemic
influenza. Emerg. Infect. Dis. 12, 66.
Lutz, A., Dyall, J., Olivo, P.D., Pekosz, A., 2005. Virus-
inducible reporter genes as a tool for detecting
and quantifying influenza A virus replication. J.
Virol. Methods 126, 13–20.
Puthavathana, P., Auewarakul, P., Charoenying, P.C.,
Sangsiriwut, K., Pooruk, P., Boonnak, K.,
Khanyok, R., Thawachsupa, P., Kijphati, R.,
Sawanpanyalert, P., 2005. Molecular
characterization of the complete genome of
human influenza H5N1 virus isolates from
Thailand. J. Gen. Virol. 86, 423–433.
Shangguan, T., Siegel, D.P., Lear, J.D., Axelsen, P.H.,
Alford, D., Bentz, J., 1998. Morphological
changes and fusogenic activity of influenza virus
hemagglutinin. Biophys. J. 74, 54–62.